Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Thymalfasin MeSH Descriptor Data 2025


MeSH Heading
Thymalfasin
Tree Number(s)
D06.472.910.850.500
D12.644.548.869.500
D12.776.922.500
Unique ID
D000077596
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000077596
Scope Note
A thymus hormone polypeptide found in thymosin fraction 5 (a crude thymus gland extract) but now produced by synthesis. It is used alone or with interferon as an immunomodulator for the treatment of CHRONIC HEPATITIS B and HEPATITIS C. Thymalfasin is also used for the treatment of chemotherapy-induced immunosuppression, and to enhance the efficacy of influenza and hepatitis B vaccines in immunocompromised patients.
Entry Term(s)
Thymosin alpha(1)
Thymosin alpha1
Zadaxin
alpha1-Thymosin
Pharm Action
Adjuvants, Immunologic
Registry Numbers
W0B22ISQ1C
0
Public MeSH Note
2019; THYMALFASIN was indexed under THYMOSIN/analogs & derivatives 1984-2018; and under THYMOSIN/analogs 1980-1983
History Note
2019 (1980)
Date Established
2019/01/01
Date of Entry
2018/07/09
Revision Date
2018/06/19
Thymalfasin Preferred
Zadaxin Narrower
page delivered in 0.157s